1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 01 DECEMBER 2014

Cancer Drug News 01 DECEMBER 2014

  • December 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - CAR-T Therapy Arena Heats Up With Another Biotech Collaboration
Industry Brief - Eisai Launches Halaven In Brazil
Industry Brief - Dr Reddy's Launches Docetaxel Injection In US
Industry Brief - FDA Grants Breakthrough Therapy Designation To Juno's T-Cell Therapy For ALL
Industry Brief - Iclusig Gains Marketing Approval In Australia
Industry Brief - Janssen To Start Daratumumab Phase II Study In SMM
Industry Brief - OBT/Menarini Group Initiate First-In-Human Study Of Enhanced Antibody For AML
Industry Brief - FDA Extends Priority Review Period For Novartis' LBH589
Industry Brief - Health Canada Approves Gazyva For Treatment Naïve CLL Patients
Industry Brief - Nordic Nanovector/Affibody Collaborate On Advanced RIT Programme For MM
Industry Brief - DSMB Recommends Continuation Of CPX-351 Phase III AML Study
Industry Brief - EC Approves BI's Vargatef For NSCLC After First-Line Chemotherapy
Industry Trend Analysis - Second Trial Failure Questions Cabozantinib's Future
Industry Brief - DSMB Recommends Continuation Of Livatag Phase III Trial In HCC
Industry Brief - Concordia Updates On Photofrin Phase III Trial; Signs Distribution Deal With Union Med
Industry Trend Analysis - Five Prime Collaboration To Aid BMS In Anti-PD-1 Race With Merck
Industry Brief - Janssen Submits Yondelis NDA To FDA For Advanced STS
Industry Trend Analysis - EORTC-NCI-AACR 2014 Emphasises Shift Towards Personalised Medicine
Industry Brief - AstraZeneca/Cancer Research UK Collaborate For Screening Of Cancer Medicines
Industry Brief - Bioniche Rebrands As Telesta Therapeutics
Industry Brief - Eisai Opens New Packaging Facility In UK For Cancer Treatment
Industry Brief - COT Raises Funds In Third Tranche Of Private Placement
Industry Brief - AbbVie Acquires API Manufacturing Facility In Singapore; Expands Capabilities In Asia
Industry Brief - CARsgen Closes Series A Financing
Industry Brief - Cancer Conferences - March 2015

Table Of Contents

Cancer Drug News 01 DECEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.